Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive Esophagitis

NCT00251719 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2054

Enrollment

INDUSTRY

Sponsor class

Conditions

Esophagitis, Reflux
Esophagitis, Peptic

Interventions

DRUG: Dexlansoprazole MR
DRUG: Dexlansoprazole MR
DRUG: Lansoprazole

Sponsor

Takeda